Metabolomics study of Resina Draconis on myocardial ischemia rats using ultraperformance liquid chromatography/quadrupole time-of-flight mass spectrometry combined with pattern recognition methods and metabolic pathway analysis

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Qi, Yunpeng ^a,b,c   Gu, Haiwei ^d,e   Song, Yunlong ^a,b,c   Dong, Xin ^a,b,c   Liu, Aijun ^a   Lou, Ziyang ^a,b,c   Fan, Guorong ^a,b,c   Chai, Yifeng ^a,b,c  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SHANGHAI KEY LABORATORY FOR PHARMACEUTICAL METABOLITE RESEARCH   (China)

^c Shanghai Research Centre for Drug Chinese Materia Medica Metabolism   (China)

^d EAST CHINA UNIVERSITY OF TECHNOLOGY   (China)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCARNITINE; AMINOACYL TRANSFER RNA; CYCLIC AMP; CYCLIC GMP; PHENYLALANINE; PHYTOSPHINGOSINE; RESIN; RESINA DRACONIS; SPHINGANINE; SPHINGOLIPID; TRYPTOPHAN; TYROSINE; UNCLASSIFIED DRUG; VALINE;

AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEART MUSCLE ISCHEMIA; LIPID METABOLISM; MALE; METABOLOMICS; NONHUMAN; PATTERN RECOGNITION; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE CONTRACTION; TIME OF FLIGHT MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ULTRAPERFORMANCE LIQUID CHROMATOGRAPHY QUADROPOLE TIME OF FLIGHT MASS SPECTROMETRY;

EID: 84879319893     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/438680     Document Type: Article

References (40)

1. Shimokawa H., Yasuda S., Myocardial ischemia: current concepts and future perspectives. Journal of Cardiology 2008 52 2 67 78 2-s2.0-52049127087 10.1016/j.jjcc.2008.07.016
2. Karmazyn M., Myocardial Ischemia: Mechanisms, Reperfusion, Protection 1996 Basel, Switzerland Birkhäuser
3. Weir R. A. P., McMurray J. J. V., Epidemiology of heart failure and left ventricular dysfunction after acute myocardial infarction. Current Heart Failure Reports 2006 3 4 175 180 2-s2.0-34948851117 10.1007/s11897-006-0019-5
4. Torabi A., Cleland J. G. F., Khan N. K., Loh P. H., Clark A. L., Alamgir F., Caplin J. L., Rigby A. S., Goode K., The timing of development and subsequent clinical course of heart failure after a myocardial infarction. European Heart Journal 2008 29 7 859 870 2-s2.0-41849135734 10.1093/eurheartj/ ehn096
5. Gupta D., Bleakley B., Gupta R. K., Dragon's blood: botany, chemistry and therapeutic uses. Journal of Ethnopharmacology 2007 115 3 361 380 2-s2.0-37549000584 10.1016/j.jep.2007.10.018
6. Xin N., Li Y. J., Li Y., Dai R. J., Meng W. W., Chen Y., Schlappi M., Deng Y. L., Dragon's Blood extract has antithrombotic properties, affecting platelet aggregation functions and anticoagulation activities. Journal of Ethnopharmacology 2011 135 2 510 514 2-s2.0-79955678071 10.1016/j.jep.2011.03. 063
7. Ma J. J., Song Y., Jia M., Li C. L., Effect of total flavone in Sanguis draconis on platelet aggregation, thrombus formation and myocardial ischemia. Chinese Traditional and Herbal Drugs 2002 33 1008 1010
8. Fang W. R., Li Y. M., Deng J. Y., Protective effect of sanguis draxonis flavones on animal myocardial ischemia. Chinese Journal of Clinical Pharmacology and Therapeutics 2005 10 1020 1024
9. Nicholson J. K., Lindon J. C., Holmes E., 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999 29 11 1181 1189 2-s2.0-0032694577
10. Nicholson J. K., Connelly J., Lindon J. C., Holmes E., Metabonomics: a platform for studying drug toxicity and gene function. Nature Reviews Drug Discovery 2002 1 2 153 161 2-s2.0-0036463681 10.1038/nrd728
11. Orešič M., Vidal-Puig A., Hänninen V., Metabolomic approaches to phenotype characterization and applications to complex diseases. Expert Review of Molecular Diagnostics 2006 6 4 575 585 2-s2.0-33746819836 10.1586/14737159.6.4.575
12. Gowda G. A. N., Zhang S., Gu H., Asiago V., Shanaiah N., Raftery D., Metabolomics-based methods for early disease diagnostics. Expert Review of Molecular Diagnostics 2008 8 5 617 633 2-s2.0-52049108458 10.1586/14737159.8.5. 617
13. Robinette S. L., Bruschweiler R., Schroeder F. C., Edison A. S., NMR in metabolomics and natural products research: two sides of the same coin. Accounts of Chemical Research 2012 45 2 288 297 10.1021/ar2001606
14. Paglia G., Hrafnsdottir S., Magnusdottir M., Fleming R. M., Thorlacius S., Palsson B. O., Thiele I., Monitoring metabolites consumption and secretion in cultured cells using ultra-performance liquid chromatography quadrupole-time of flight mass spectrometry (UPLC-Q-ToF-MS). Analytical and Bioanalytical Chemistry 2012 402 3 1183 1198 10.1007/s00216-011-5556-4
15. Scalbert A., Brennan L., Fiehn O., Hankemeier T., Kristal B. S., van Ommen B., Pujos-Guillot E., Verheij E., Wishart D., Wopereis S., Mass-spectrometry-based metabolomics: limitations and recommendations for future progress with particular focus on nutrition research. Metabolomics 2009 5 4 435 458 2-s2.0-74449085466 10.1007/s11306-009-0168-0
16. Jorgensen L. H., Thaulow E., Refsum H. E., Early hemodynamic effects at rest with acute and chronic isosorbide dinitrate treatment in patients with ischemic heart disease. Clinical Cardiology 1995 18 8 455 459 10.1002/clc.4960180806
17. Jerie P., Milestones of cardiovascular therapy. III. Nitroglycerin. Casopis Lékaru Ceských 2007 146 6 533 537
18. Ytrehus K., Models of myocardial ischemia. Drug Discovery Today: Disease Models 2006 3 3 263 271 2-s2.0-33751242013 10.1016/j.ddmod.2006.10.013
19. Trygg J., Holmes E., Lundstedt T., Chemometrics in metabonomics. Journal of Proteome Research 2007 6 2 469 479 2-s2.0-33847369007 10.1021/pr060594q
20. Chagoyen M., Pazos F., MBRole: enrichment analysis of metabolomic data. Bioinformatics 2011 27 5 730 731 2-s2.0-79951999565 10.1093/bioinformatics/ btr001 btr001
21. Zheng S. Y., Sun J., Zhao X., Xu J. G., Protective effect of Shen-Fu on myocardial ischemia-reperfusion injury in rats. The American Journal of Chinese Medicine 2004 32 2 209 220 2-s2.0-3543023960 10.1142/S0192415X04001874
22. Todorovski T., Fedorova M., Hoffmann R., Mass spectrometric characterization of peptides containing different oxidized tryptophan residues. Journal of Mass Spectrometry 2011 46 10 1030 1038 10.1002/jms.1984
23. Anderson D. N., Wilkinson A. M., Abou-Saleh M. T., Blair J. A., Recovery from depression after electroconvulsive therapy is accompanied by evidence of increased tetrahydrobiopterin-dependent hydroxylation. Acta Psychiatrica Scandinavica 1994 90 1 10 13 2-s2.0-0028240517
24. Rosenblatt D., Scriver C. R., Heterogeneity in genetic control of phenylalanine metabolism in man. Nature 1968 218 5142 677 678 2-s2.0-0014421994 10.1038/218677a0
25. Jiang P., Dai W., Yan S., Chen Z., Xu R., Ding J., Xiang L., Wang S., Liu R., Zhang W., Potential biomarkers in the urine of myocardial infarction rats: a metabolomic method and its application. Molecular BioSystems 2011 7 3 824 831 2-s2.0-79951651095 10.1039/c0mb00110d
26. Tan G., Lou Z., Liao W., Dong X., Zhu Z., Li W., Chai Y., Hydrophilic interaction and reversed-phase ultraperformance liquid chromatography TOF-MS for serum metabonomic analysis of myocardial infarction in rats and its applications. Molecular BioSystems 2012 8 2 548 556 10.1039/c1mb05324h
27. Morgado M., Cairrao E., Santos-Silva A. J., Verde I., Cyclic nucleotide-dependent relaxation pathways in vascular smooth muscle. Cellular and Molecular Life Sciences 2012 69 2 247 266 10.1007/s00018-011-0815-2
28. Sperelakis N., Regulation of calcium slow channels of heart by cyclic nucleotides and effects of ischemia. Advances in Pharmacology 1994 31 1 24 2-s2.0-0028697372 10.1016/S1054-3589(08)60605-5
29. Naryzhnaya N. V., Maslov L. N., Lishmanov Y. B., Kolář F., Effect of stress adaptation on cyclic nucleotide content in myocardial tissue during acute ischemia/reperfusion. Bulletin of Experimental Biology and Medicine 2008 145 5 588 591 2-s2.0-55649087097 10.1007/s10517-008-0138-y
30. du Toit E. F., Opie L. H., Modulation of severity of reperfusion stunning in the isolated rat heart by agents altering calcium flux at onset of reperfusion. Circulation Research 1992 70 5 960 967 2-s2.0-0026561493
31. Xuan Y. T., Tang X. L., Qiu Y., Banerjee S., Takano H., Han H., Bolli R., Biphasic response of cardiac NO synthase isoforms to ischemic preconditioning in conscious rabbits. The American Journal of Physiology 2000 279 5 H2360 H2371 2-s2.0-0033668478
32. 2+ current in single heart cells. Nature 1986 323 6085 273 275 2-s2.0-0022455840
33. 2+ current in rat ventricular myocytes. Circulation Research 1995 77 4 803 812 2-s2.0-0029095970
34. Madison K. C., Swartzendruber D. C., Wertz P. W., Downing D. T., Sphingolipid metabolism in organotypic mouse keratinocyte cultures. Journal of Investigative Dermatology 1990 95 6 657 664 2-s2.0-0025608244
35. Gundewar S., Lefer D. J., Sphingolipid therapy in myocardial ischemia-reperfusion injury. Biochimica et Biophysica Acta 2008 1780 3 571 576 2-s2.0-40749135742 10.1016/j.bbagen.2007.08.014
36. Choy P. C., Chan M., Hatch G., Man R. Y. K., Phosphatidylcholine metabolism in ischemic and hypoxic hearts. Molecular and Cellular Biochemistry 1992 116 1-2 53 58 2-s2.0-0026497964 10.1007/BF01270569
37. Lohmann S. M., Fischmeister R., Walter U., Signal transduction by cGMP in heart. Basic Research in Cardiology 1991 86 6 503 514 2-s2.0-0026337607 10.1007/BF02190700
38. Pavoine C., Pecker F., Sphingomyelinases: their regulation and roles in cardiovascular pathophysiology. Cardiovascular Research 2009 82 2 175 183 2-s2.0-67449110914 10.1093/cvr/cvp030
39. McNulty P. H., Jacob R., Deckelbaum L. I., Young L. H., Effect of hyperinsulinemia on myocardial amino acid uptake in patients with coronary artery disease. Metabolism: Clinical and Experimental 2000 49 10 1365 1369 2-s2.0-0033783899 10.1053/meta.2000.9510
40. Virmani A., Binienda Z., Role of carnitine esters in brain neuropathology. Molecular Aspects of Medicine 2004 25 5-6 533 549 2-s2.0-4444289045 10.1016/j.mam.2004.06.003